UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Long-term Outcomes After Bladder-Preserving Combined Modality Therapy for Patients With Muscle-Invasive Bladder Cancer

International journal of radiation oncology, biology, physics, 2015-11, Vol.93 (3), p.S22-S23

2015

Volltextzugriff (PDF)

The Natural History of Nonmuscle-Invasive Bladder Cancer Recurrences After Complete Response to Combined-Modality Organ-Preserving Therapy for Muscle-Invasive Bladder Cancer

International journal of radiation oncology, biology, physics, 2016-10, Vol.96 (2), p.S95-S95

2016

Volltextzugriff (PDF)

Report of NRG Oncology/RTOG 9601, A Phase 3 Trial in Prostate Cancer: Anti-androgen Therapy (AAT) With Bicalutamide During and After Radiation Therapy (RT) in Patients Following Radical Prostatectomy (RP) With pT2-3pN0 Disease and an Elevated PSA

International journal of radiation oncology, biology, physics, 2016, Vol.94 (1), p.3-3

2016

Volltextzugriff (PDF)

Multimodality Management in Primary Urethral Cancer: The Role of Radiation Therapy

International journal of radiation oncology, biology, physics, 2013-10, Vol.87 (2), p.S402-S402

2013

Volltextzugriff (PDF)

Selective bladder conservation using transurethral resection, chemotherapy, and radiation: management and consequences of Ta, T1, and Tis recurrence within the retained bladder

Urology (Ridgewood, N.J.), 2001-09, Vol.58 (3), p.380-385

2001

Volltextzugriff (PDF)

Long-term Outcomes After Bladder Preserving Combined Modality Therapy for Muscle-invasive Bladder Cancer: A Pooled Analysis of RTOG 8802, 8903, 9506, 9706, 9906, and 0233

International journal of radiation oncology, biology, physics, 2012-11, Vol.84 (3), p.S121-S121

2012

Volltextzugriff (PDF)

Nomogram for Predicting Risk of Cystectomy or Recurrence after Bladder Preserving Trimodality Therapy for Muscle Invasive Bladder Cancer

International journal of radiation oncology, biology, physics, 2011, Vol.81 (2), p.S71-S71

2011

Volltextzugriff (PDF)

Initial Report of RTOG 9601: A Phase III Trial in Prostate Cancer: Anti-androgen Therapy (AAT) with Bicalutamide during and after Radiation Therapy (RT) Improves Freedom from Progression and Reduces the Incidence of Metastatic Disease in Patients following Radical Prostatectomy (RP) with pT2-3, N0 Disease, and Elevated PSA Levels

International journal of radiation oncology, biology, physics, 2010, Vol.78 (3), p.S27-S27

2010

Volltextzugriff (PDF)

Fifteen-year Outcomes of Selective Bladder Preservation by Combined Modality Therapy for Invasive Bladder Cancer: The Long-term MGH Experience

International journal of radiation oncology, biology, physics, 2009, Vol.75 (3), p.S10-S11

2009

Volltextzugriff (PDF)

Selective bladder preservation by combined modality protocol treatment: long-term outcomes of 190 patients with invasive bladder cancer

Urology (Ridgewood, N.J.), 2002-07, Vol.60 (1), p.62-67

2002

Volltextzugriff (PDF)

Defining Biochemical Control After Prostate Brachytherapy: Can We Use a Target PSA?

International journal of radiation oncology, biology, physics, 2005-10, Vol.63, p.S309-S310

2005

Volltextzugriff (PDF)

Definitions of biochemical control after permanent interstitial brachytherapy as sole treatment for localized prostate cancer: Interpreting the psa bounce

International journal of radiation oncology, biology, physics, 2004-09, Vol.60 (1), p.S444-S444

2004

Volltextzugriff (PDF)

A PHASE I/II TRIAL OF TRANSURETHRAL SURGERY COMBINED WITH CONCURRENT CISPLATIN, 5-FLUOROURACIL AND TWICE DAILY RADIATION FOLLOWED BY SELECTIVE BLADDER PRESERVATION IN OPERABLE PATIENTS WITH MUSCLE INVADING BLADDER CANCER

The Journal of urology, 1998-11, Vol.160 (5), p.1673-1677

1998

Volltextzugriff (PDF)

Case 33-1992: A 34-Year-Old Woman with Endometriosis and Bilateral Hydronephrosis

The New England journal of medicine, 1992-08, Vol.327 (7), p.481-485

1992

Volltextzugriff (PDF)

Selective bladder preservation by combined modality treatment of invasive bladder cancer: 10-Year outcome

International journal of radiation oncology, biology, physics, 2001-11, Vol.51 (3), p.13-14

2001

Volltextzugriff (PDF)

RTOG 9706: initial report of a phase I/II trial of bladder-conservation employing TURB, accelerated irradiation sensitized with Cisplatin followed by adjuvant MCV chemotherapy

International journal of radiation oncology, biology, physics, 2001-11, Vol.51 (3), p.14-14

2001

Volltextzugriff (PDF)

Organ conservation as an alternative to radical cystectomy for invasive bladder cancer: urodynamic and quality of life evaluation of patients treated by trimodality therapy

International journal of radiation oncology, biology, physics, 2002-10, Vol.54 (2), p.62-62

2002

Volltextzugriff (PDF)

First-Line Chemotherapy of Superficial Bladder Cancer: Mitomycin vs Thiotepa

The Journal of urology, 1986-08, Vol.136 (2), p.542-543

Heney, N.M.

1986

Volltextzugriff (PDF)

The value of external beam radiation in node positive prostate cancer

Urologic oncology, 2001-11, Vol.6 (6), p.255-260

2001

Volltextzugriff (PDF)

145 Initial results of RTOG 95-06: A phase I/II trial of transurethral surgery and fractionated twice-daily radiation with concurrent cisplatin and 5-fluorouracil followed either by selective bladder preservation or cystectomy for patients with muscle-invading bladder cancer

International journal of radiation oncology, biology, physics, 1999, Vol.45 (3), p.222-222

1999

Volltextzugriff (PDF)

Phase III Trial of Neoadjuvant Chemotherapy in Patients With Invasive Bladder Cancer Treated With Selective Bladder Preservation by Combined Radiation Therapy and Chemotherapy: Initial Results of Radiation Therapy Oncology Group 89-03

The Journal of urology, 1999-08, Vol.162 (2), p.623-624

1999

Volltextzugriff (PDF)

The value of external beam radiation in node positive prostate cancer: a multivariate analysis

Urologic oncology, 2001, Vol.6 (6), p.255-260

2001

Volltextzugriff (PDF)

41 [formula omitted]: A Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy

International journal of radiation oncology, biology, physics, 1997, Vol.39 (2), p.155-155

1997

Volltextzugriff (PDF)

42 A phase [formula omitted] trial of transurethral surgery plus cisplatin and radiation therapy followed by either selective bladder preservation or radical cystectomy for patients with muscle-invading bladder cancer but without hydronephrosis

International journal of radiation oncology, biology, physics, 1997, Vol.39 (2), p.155-155

1997

Volltextzugriff (PDF)

1141 Selective bladder preservation by combined modality therapy for invasive bladder cancer

European journal of cancer (1990), 1995-11, Vol.31, p.S239-S239

1995

Volltextzugriff (PDF)

1 – 25 von 41

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(41)

Sprache

Englisch
(41)

Erscheinungsjahr

n.n

Zeitschrift / Serie

International Journal Of Radiation Oncology, Biology, Physics
(25)
The Journal Of Urology
(7)
Urology
(4)
Urologic Oncology
(2)
European Journal Of Cancer
(1)
Pathology
(1)
The New England Journal Of Medicine
(1)

2 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Long-term Outcomes After Bladder-Preserving Combined Modality Therapy for Patients With Muscle-Invasive Bladder Cancer

The Natural History of Nonmuscle-Invasive Bladder Cancer Recurrences After Complete Response to Combined-Modality Organ-Preserving Therapy for Muscle-Invasive Bladder Cancer

Report of NRG Oncology/RTOG 9601, A Phase 3 Trial in Prostate Cancer: Anti-androgen Therapy (AAT) With Bicalutamide During and After Radiation Therapy (RT) in Patients Following Radical Prostatectomy (RP) With pT2-3pN0 Disease and an Elevated PSA

Multimodality Management in Primary Urethral Cancer: The Role of Radiation Therapy

Selective bladder conservation using transurethral resection, chemotherapy, and radiation: management and consequences of Ta, T1, and Tis recurrence within the retained bladder

Long-term Outcomes After Bladder Preserving Combined Modality Therapy for Muscle-invasive Bladder Cancer: A Pooled Analysis of RTOG 8802, 8903, 9506, 9706, 9906, and 0233

Nomogram for Predicting Risk of Cystectomy or Recurrence after Bladder Preserving Trimodality Therapy for Muscle Invasive Bladder Cancer

Fifteen-year Outcomes of Selective Bladder Preservation by Combined Modality Therapy for Invasive Bladder Cancer: The Long-term MGH Experience

Selective bladder preservation by combined modality protocol treatment: long-term outcomes of 190 patients with invasive bladder cancer

Defining Biochemical Control After Prostate Brachytherapy: Can We Use a Target PSA?

Definitions of biochemical control after permanent interstitial brachytherapy as sole treatment for localized prostate cancer: Interpreting the psa bounce

A PHASE I/II TRIAL OF TRANSURETHRAL SURGERY COMBINED WITH CONCURRENT CISPLATIN, 5-FLUOROURACIL AND TWICE DAILY RADIATION FOLLOWED BY SELECTIVE BLADDER PRESERVATION IN OPERABLE PATIENTS WITH MUSCLE INVADING BLADDER CANCER

Case 33-1992: A 34-Year-Old Woman with Endometriosis and Bilateral Hydronephrosis

Selective bladder preservation by combined modality treatment of invasive bladder cancer: 10-Year outcome

RTOG 9706: initial report of a phase I/II trial of bladder-conservation employing TURB, accelerated irradiation sensitized with Cisplatin followed by adjuvant MCV chemotherapy

Organ conservation as an alternative to radical cystectomy for invasive bladder cancer: urodynamic and quality of life evaluation of patients treated by trimodality therapy

First-Line Chemotherapy of Superficial Bladder Cancer: Mitomycin vs Thiotepa

The value of external beam radiation in node positive prostate cancer

145 Initial results of RTOG 95-06: A phase I/II trial of transurethral surgery and fractionated twice-daily radiation with concurrent cisplatin and 5-fluorouracil followed either by selective bladder preservation or cystectomy for patients with muscle-invading bladder cancer

Phase III Trial of Neoadjuvant Chemotherapy in Patients With Invasive Bladder Cancer Treated With Selective Bladder Preservation by Combined Radiation Therapy and Chemotherapy: Initial Results of Radiation Therapy Oncology Group 89-03

The value of external beam radiation in node positive prostate cancer: a multivariate analysis

41 [formula omitted]: A Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy

42 A phase [formula omitted] trial of transurethral surgery plus cisplatin and radiation therapy followed by either selective bladder preservation or radical cystectomy for patients with muscle-invading bladder cancer but without hydronephrosis

1141 Selective bladder preservation by combined modality therapy for invasive bladder cancer

Suchergebnisse filtern